Net Cash Provided by (Used in) Investing Activities of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
TC BioPharm (Holdings) plc annual and quarterly Net Cash Provided by (Used in) Investing Activities in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was £5,618, a 96% increase year-over-year.
  • TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Investing Activities for 2024 was £92,514, a 56% increase from 2023.
  • TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Investing Activities for 2023 was £208,789, a 33% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (GBP)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Investing Activities, Quarterly (GBP)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Annual Net Cash Provided by (Used in) Investing Activities (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 £92,514 +£116,275 +56% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY
2023 £208,789 +£101,408 +33% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025 2024 FY
2022 £310,197 01 Jan 2022 31 Dec 2022 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Quarterly Net Cash Provided by (Used in) Investing Activities (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 £5,618 +£139,615 +96% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 £145,233 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.